An Australian Living Guideline for the Management of Juvenile Idiopathic Arthritis

Published by William Renton on Nov 23, 2021

Disclaimer

Sponsors

Contact

Abstract

A subgroup of the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis

Language

en

PICOS

PICO 1.1

Population
Children and young people with a diagnosis of juvenile idiopathic arthritis (JIA) as per the International League Against Rheumatism (ILAR) criteria or earlier equivalents who have JIA associated uveitis that is inadequately controlled by methotrexate Arthritis, Juvenile D001171, Uveitis D014605,
Intervention
Any biologic or targeted synthetic disease modifying anti-rheumatic drug Arthritis, Juvenile D001171, Uveitis D014605,
Comparator
Placebo Arthritis, Juvenile D001171, Uveitis D014605,
Outcomes
Arthritis, Juvenile D001171, Uveitis D014605,